Agreed. A “buying opportunity” now would entail either another massive short attack, or less than stellar news regarding efficacy.

Or both.

I’m ready to start making some real $$, and I’m ready to see Leronlimab saving lives and livelihoods.

Hey NP, good news, or no news Thursday please.